The adoption of accurate non-invasive measures of liver health at the point of care is critical.
This is the second alert the agency has issued in less than one year.
The agency has alerted healthcare providers of unanticipated deaths related to the systems intended to treat obesity.
A lack of quality, locally made products opens the door for Western device companies.
As the incidence of diabetes across Asia expands, demand for medical devices and drugs to treat the disease is intensifying.